Immune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients.
Support Care Cancer
; 30(5): 4019-4026, 2022 May.
Article
in En
| MEDLINE
| ID: mdl-35064328
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Medicare Part C
/
Neoplasms
Type of study:
Health_economic_evaluation
/
Observational_studies
Aspects:
Implementation_research
Limits:
Adult
/
Aged
/
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Support Care Cancer
Journal subject:
NEOPLASIAS
/
SERVICOS DE SAUDE
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Alemania